U
TNDM icon

UBS’s Tandem Diabetes Care TNDM Stock Holding History

UBS’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3K Sell
20
-347
-95% -$48.6K ﹤0.01% 9820
2014
Q2 		$60K Buy
367
+335
+1,047% +$57K ﹤0.01% 6632
2014
Q1 		$7K Buy
+32
New +$8.16K ﹤0.01% 9268

Other funds holding TNDM

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS's TNDM Position: Q3 2014 in Review

UBS reduced its Tandem Diabetes Care (TNDM) stake by 95% in Q3 2014, selling an estimated $48.6K and leaving 20 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #9820.

UBS first reported a position in TNDM in Q1 2014 and has held it in 3 quarters since. The position peaked at $60K in Q2 2014. 69 funds tracked by Wall St. Rank hold TNDM as of Q3 2014.

  • UBS held 20 shares of Tandem Diabetes Care worth $3K as of Q3 2014.
  • UBS sold 347 Tandem Diabetes Care shares in Q3 2014, an estimated $48.6K.
  • Tandem Diabetes Care made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9820 holding.
  • UBS first reported a position in Tandem Diabetes Care in Q1 2014 and has held it in 3 quarters since.
  • UBS's Tandem Diabetes Care position peaked at $60K in Q2 2014.
  • 69 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.